Nebraska Cancer Specialists (NCS) has been named a Center of Excellence (COE) by GO2 for Lung Cancer (GO2) in both Lung Cancer Screening and Lung Cancer Care, recognizing the organization’s commitment to delivering patient-centered, evidence-based services across the full lung cancer continuum.  An estimated 237,000 Americans are diagnosed with lung cancer each year, and the disease remains the leading cause of cancer-related deaths in the U.S. Early detection through low-dose CT (LDCT) screening and advances in treatment are transforming outcomes, helping more people live longer, higher-quality lives.